Craig Atwood, PhD, is conducting a research study at the University of Wisconsin-Madison Department of Medicine to see if the drug Eligard (leuprolide acetate) may be effective against Alzheimer’s disease in women.

Have you or a loved one been diagnosed with Mild Cognitive Impairment or Alzheimer’s Disease? This study is open to women over the age of 65 diagnosed with Alzheimer’s Disease who are taking a stable dose of a cholinesterase inhibitor medication such as donepezil (Aricept). Participants must also have a study partner (friend or family member) who can accompany them to all study visits.

Study Activities: Our study team will ask you to complete eight study visits spread out over one year.

• There will be an injection of the study drug (Leuprolide or placebo) four times over the one-year study
• Study visits will include tests of thinking abilities, blood tests, two MRI scans, and one PET scan
• Some parts of some visits may be done remotely via phone, computer, or other electronic means

compensation: For participating in our study, participants will be paid $50 for each completed study visit and you may be eligible to be reimbursed for travel costs depending on the distance traveled.

Interested?    You can fill out the interest form here: Study Interest Form

You can also call, text, email, or visit our website for more information:

608-263-2704 | mchilsen@clinicaltrials.wisc.edu | LUCINDA